EXPANDED PROGRAMME ON IMMUNIZATION — Vaccine Importer Profile
Pharmaceutical Importer · #11 buyer for Vaccine · $3.6M import value · 72 shipments · PAKISTAN · DGFT Verified
EXPANDED PROGRAMME ON IMMUNIZATION is the #11 importer of Vaccine from India with $3.6M in import value and 72 verified shipments. EXPANDED PROGRAMME ON IMMUNIZATION holds a 0.5% market share in Vaccine imports based in PAKISTAN. The company sources from 4 verified suppliers across 19 formulations shipped to 1 country.
EXPANDED PROGRAMME ON IMMUNIZATION — Vaccine Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vaccine to EXPANDED PROGRAMME ON IMMUNIZATION?
Verified from 72 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| BIOLOGICAL E. LIMITED | $2.7M | 55 | 76.2% |
| SERUM INSTITUTE OF INDIA PRIVATE LIMITED | $497.6K | 10 | 14.0% |
| PANACEA BIOTEC LIMITED | $250.0K | 5 | 7.0% |
| BIOLOGICAL E LIMITED | $100.0K | 2 | 2.8% |
EXPANDED PROGRAMME ON IMMUNIZATION sources Vaccine from 4 verified Indian suppliers based on 72 customs records. The primary supplier is BIOLOGICAL E. LIMITED accounting for 76.2% of imports.
How Does EXPANDED PROGRAMME ON IMMUNIZATION Compare to Nearest Vaccine Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | EXPANDED PROGRAM ON IMMUNIZATION | PAKISTAN | $2.4M | 48 | $50.0K |
| 9 | XXICEXXSUPXXY DXXISIXX | AFGHANISTAN | $2.4M | 48 | $50.0K |
| 11 | EXPANDED PROGRAMME ON IMMUNIZATION ★ | PAKISTAN | $2.3M | 45 | $50.0K |
| 13 | CENTURION ILAC SANAYI VE TICARET AN | TURKEY | $2.1M | 42 | $50.0K |
| 3 | NATIONAL VACCINES AND IMMUNIZATION | KENYA | $1.9M | 37 | $50.0K |
EXPANDED PROGRAMME ON IMMUNIZATION ranks #11 among 2,202 Vaccine importers from India. Average shipment value of $50.0K compared to the market average of $17.3K. The closest competitors by value are EXPANDED PROGRAM ON IMMUNIZATION and XXICEXXSUPXXY DXXISIXX.
Where Does EXPANDED PROGRAMME ON IMMUNIZATION Import Vaccine To?
Destination countries from 72 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PAKISTAN | $3.6M | 72 | 100.0% |
EXPANDED PROGRAMME ON IMMUNIZATION imports Vaccine to 1 country. The primary destination is PAKISTAN receiving 100.0% of shipments worth $3.6M.
What Vaccine Formulations Does EXPANDED PROGRAMME ON IMMUNIZATION Import?
| Formulation | Value | Shipments |
|---|---|---|
| DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY LIQUID COMBINATION VACCINE,SINGLE DOSE | $800.0K | 16 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLY | $650.0K | 13 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATIONV ACCINE,SINGLE DOSEVIAL(0.5ML) VIAL,PEDIATRIC DOSE | $400.0K | 8 |
| [SINGLE VACCINES FOR TB (TUBERCULOSIS)] | $300.0K | 6 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-H | $300.0K | 6 |
| EASY FIVE TT VACCINE DTwP-HepB-HIB PENTA | $150.0K | 3 |
| [MIXED VACCINES FOR DIPTHERIA AND TETANUS] DIPHTHERIA & TETANUS VACCINE (ADULT)20 DOSE WITH VVM VACCINE FOR HUMAN MEDIVLS | $147.6K | 3 |
| TD VACCINE ADSORBED TETANUS AND DIPHTHERIA VACCINE ADULT DOSE, VIAL OF 20 DOSESWITH VACCINE VIAL MONITOR (VVM) | $125.8K | 3 |
| TYPHOID CONJUGATE VACCINE MONOVALENT 5 DOSE 2.5ML VIAL WITH VACCINE VIAL MONITOR(VVM) | $100.0K | 2 |
| DTP-HEPB-HIB (PENTAVALENT VACCINE) FULLYLIQUID COMBINATIONV ACCINESINGLE DOSEVIAL(0.5ML) VIALPEDIATRIC DOSE | $100.0K | 2 |
EXPANDED PROGRAMME ON IMMUNIZATION imports 19 distinct Vaccine formulations from India. The top formulation is DTP-HEPB-HIB (PENTAVALENT VACCINE) DTP-HEPB-HIB (PENTAVALENT with 16 shipments worth $800.0K.
Who Are the Top Buyers of Vaccine from India and How Much Does EXPANDED PROGRAMME ON IMMUNIZATION Import?
India exported $38.1M worth of Vaccine through 14,355 shipments from 325 suppliers to 192 countries, serving 2,202 buyers globally. EXPANDED PROGRAMME ON IMMUNIZATION imports $3.6M of this total, accounting for 0.5% of India's Vaccine exports with 72 shipments from PAKISTAN. This is verified from 72 customs shipment records covering 19 distinct formulations.
What Is the Average Order Value for EXPANDED PROGRAMME ON IMMUNIZATION's Vaccine Imports?
EXPANDED PROGRAMME ON IMMUNIZATION's average Vaccine order value is $49.4K per consignment, based on 72 shipments totaling $3.6M. EXPANDED PROGRAMME ON IMMUNIZATION is based in PAKISTAN and ranks #11 among all Vaccine importers from India by value. The company sources from 4 verified suppliers in India.
Who Supplies Vaccine to EXPANDED PROGRAMME ON IMMUNIZATION?
EXPANDED PROGRAMME ON IMMUNIZATION sources Vaccine from 4 verified Indian suppliers: BIOLOGICAL E. LIMITED ($2.7M, 76.2%), SERUM INSTITUTE OF INDIA PRIVATE LIMITED ($497.6K, 14.0%), PANACEA BIOTEC LIMITED ($250.0K, 7.0%), BIOLOGICAL E LIMITED ($100.0K, 2.8%). This is based on 72 customs records.
How Does EXPANDED PROGRAMME ON IMMUNIZATION Compare to Other Vaccine Importers?
EXPANDED PROGRAMME ON IMMUNIZATION ranks #11 among 2,202 Vaccine importers from India with a 0.5% market share. The top 3 importers are NATIONAL PRIMARY HEALTH CARE ($6.3M), UNICEF SUPPLY DIVISION ($5.0M), MINISTRY OF HEALTH ($4.5M). EXPANDED PROGRAMME ON IMMUNIZATION processed 72 shipments from PAKISTAN.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vaccine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vaccine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EXPANDED PROGRAMME ON IMMUNIZATION matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EXPANDED PROGRAMME ON IMMUNIZATION's capped import value divided by total capped export value for Vaccine across all Indian exporters.
- 5.Verified Records: This page is backed by 72 individual customs records matching EXPANDED PROGRAMME ON IMMUNIZATION importing Vaccine, covering 19 formulations from 4 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 192+ countries, 2,202+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vaccine Import Data for EXPANDED PROGRAMME ON IMMUNIZATION
Access order-level details, pricing data, supplier connections, and competitive analysis for EXPANDED PROGRAMME ON IMMUNIZATION's Vaccine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EXPANDED PROGRAMME ON IMMUNIZATION
Company Profile
Multiple products · $0 total trade · Multiple categories
EXPANDED PROGRAMME ON IMMUNIZATION × Vaccine
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EXPANDED PROGRAMME ON IMMUNIZATION.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vaccine. For current order-level data, contact TransData Nexus.